Saturday, October 10, 2026

Back to today

From X

BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

Boyz in the Hood

Robinhood’s AI agents, 24/7 equity trading and 10:1 crypto perpetual futures encourage higher retail trading velocity, leverage and…

Namib Minerals: Research Note

Namib Minerals posted H1 adjusted EBITDA of $19.0 million, up 76%, as higher gold prices offset lower production.

Publications we follow

Every publication on this site, hand-picked.

127 publications

Newsletters 106

X accounts we follow

Every account on this site, hand-picked.

84 accounts

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.